Member Info for Fredd1eboy

Well done GMS....wish I could top up further but that's my last trading stint until the piggy Bank is replenished

Https://www.linkedin.com/posts/the-aptamer-group_optimer-aptamers-therapeutics-activity-7330872497573109762-LRMQ?utm_source=share&utm_medium=member_android&rcm=ACoAAAx41aAB-s-GG7MzyP5t-m_sVg2s5QnfYRI

..unfortunately many investors are historically left in the dark by companies, being used solel as a money pit

It's not like that with Aptamer, Arron, Adam and the entire scientific/business team. Read above

I'm on your wavelength ant.....having been steadily increasing my stake whilst the sp is way way undervalued now, at thee current silly low valuation of a tiny £7 to £8m.......I will now just sit back and await a well deserved stream of value added news.....I'm sure we will look back in 12 months and joke about our historical valuations....like a helter-skelter we await the slow drag of the line from the bottom to the peak and then in a few, days, weeks or months we fly. Good luck my friend

Advise to potential new investors,...load up while you can https://www.britishbulls.com/SignalPage.aspx?lang=en&Ticker=APTA.L

Https://www.britishbulls.com/SignalPage.aspx?lang=en&Ticker=APTA.L

100% agreed bobbust.....their products/services virtually unique and hungry to capitalise on them, via blue chip customers....I'm 100% certain they are giving their all through excellent marketing initiatives....What's not to like and to top it off....the sp is currently way undervaluing the unique, diverfied, initiatives on offer....well done Arron/Adam and team.

Blue skies at last......some savvy investors buying in, whilst the sp is a low priced bargain.

Many thanks ant....and agreed good enough to me too

Hi parsons.....I'm a retired manufacturing engineering executive......having diversified from Civil and Structural Engineering many moons ago. No pharma background at all....but have so much respect for anyone focused on eliminating unnecessary suffering.

As for Jargon, agreed its technically complex. I try to think of it a friendly intrusion of a 100% accurate carrier delivering a non biological miracle payload entering a nasty intrusion In a cell (or smaller) with 100% accuracy.....So, as for cancer, which is close to our hearts, it can be treated with 100% accuracy without the dreaded poisoning side effects. A game changer... and Aptamer is uniquely non biological, thus neutralising any unwanted ethical debate. As for carrying any other payload, Aptamers scope of application is pretty well endless. What's not to like....consider loading up, whilst the naysayers keep wittering on and putting some of the uninformed off

Good morning Parsons.....As for funding....I've been assured from both Arron CEO and their chairman Adam.... that funding will not be an issue.....that's enough for me....and that's why I've been loading up stock and will continue to do so whilst there is any sign of negativity......My advice....DYOR and ignore the witterer on ADVFN

Https://hubs.li/Q03mWv0L0

Market Outlook

The LAST pattern detected was BULLISH, indicating POSITIVE implications. The overall evidence, however, is saying “Watch Out!” but it is not yet pointing to BUY. The share price is still not above the confirmation level and the signal is suggesting to STAY IN CASH, but the chance of a bullish confirmation that will change the signal to BUY IS VERY HIGH. The Delayed Intraday Module is ON. We highly recommend closely monitoring intraday price movements to MAXIMISE PROFITS DURING THE INITIAL PHASE OF A BULL RUN .

As a layman, as I see it, the Aptamer-Group designs its unique treatments for precision targeting....

The obvious application is for delivering the cancer treatment directly to the rogue cell and disarming it without damaging/poisoning adjacent/integral healthy cells....So plenty of scope for their development both for vetinary and human treatments, especiallyas they are non biological.

So as non biological....they will not fall in the ethically unsuitable treatments trap...."ala Reneurons stem cell/ exesome harvesting"

Moving on....the scope of applications is pretty well infinite....so I'm sure Aptamer will prioritise its applications/designs to maximise it commercial and ethical potential...As a layman....even I can see Aptamers potential is huge....they must surely be in the cross/wires of its several mega peers....

Consequently, I'm accumulating at these current silly low share prices....whilst frustrated by non-existent future funding fears... however they cannot stop DoubtingThomas from airing groundless fears.....if asked, my recommendation would be to ignore and accumulate whilst these fears subside via education and example

Last post. Read Shareholder's in title.....and thanks Aptamer team ....your continued respect and appreciation of investor support appreciated.

Hi Frederick

In case you missed it, Optimers have been in the news, with success across many different fields and applications.

Working with partners at Glasgow University, Optimers have been shown to work as vaccine adjuvants. These binders are now being progressed for use in veterinary vaccines.

In partnership with Neuro-Bio, we have translated our early diagnostic test for Alzheimer's disease into an ELISA format for easy integration into hospital systems.

Our enzyme modulating Optimer for use in PCR assays have been successfully trialled in a customer lab and out-licensed for use.

Our liver fibrosis drug delivery vehicle has shown compatibility with multiple fibrotic tissues for broader disease targeting.

Check out some of the news below to find out more

.....I'm guessing, if the sp rises slightly, they will be reported later as sells.....Great future ahead for those buying at these silly, low prices. Further value added positive financial news WILL be stratospheric.....just DYOR.....writings on the wall.

From New Orleans.....I wish I understood the Chemistry & Physics behind Aptamers various initiatives.

However, I can only give 100% support to the effort Arron and his team are putting in marketing their exceptionally wide scope applications of their technology amongst their pretty endless pier groups. I've worked between the US/UK and know how exhausting it can be, particularly if it involves seven day stints and associated disruption to family life.

So, 100% well done to the marketing team. I know that I'm a tidler of an investor but nonetheless you have my continued 100% support. Cancer will be tamed, that I'm sure of.

....value added week for Aptamer.....once the market accurately revalues the company....the sp will recover and then rise to a realistic value......patience required until the penny drops...Inbthe meantime we must surely be a buy...... just DYOR.,..and all will be revealed........

...marked up as sells....dyor